Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank71
5Y CAGR-20.2%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-20.2%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202526.31%
2024-53.74%
20233.30%
2022-37.68%
2021-11.28%
202081.07%
201936.01%
20180.00%